The Medical University of Gdańsk is the largest medical academic institution in northern Poland. It educates more than 5000 undergraduate and postgraduate students in four faculties.

During the past decade, Gdanski Uniwersytet Medyczny conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gdanski Uniwersytet Medyczny" #1 sponsor was "Shire" with 2 trials, followed by "Baxter Healthcare Corporation" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored, "Ferring Pharmaceuticals" with 1 trials sponsored and "Fundacao Champalimaud" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gdanski Uniwersytet Medyczny" #1 collaborator was "Gambro Lundia AB" with 1 trials as a collaborator, "National Center for Research and Development, Poland" with 1 trials as a collaborator, "RCTs" with 1 trials as a collaborator, "Statistical Analysis : CIC CHU Brabois Nancy" with 1 trials as a collaborator and "Zoll Medical Corporation" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Gdanski Uniwersytet Medyczny" are "ADHD" (2 trials), "Breast Cancer" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Chronic Heart Failure" (1 trials) and "Chronic Kidney Disease" (1 trials). Many other conditions were trialed in "Gdanski Uniwersytet Medyczny" in a lesser frequency.

Most popular intervention types in "Gdanski Uniwersytet Medyczny" are "Device" (5 trials), "Drug" (5 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Artificial Intelligence and Digital Health Arm" (1 trials), "Best local cares" (1 trials), "Degarelix 10 mg" (1 trials) and "Degarelix 20 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gdanski Uniwersytet Medyczny" are 10 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Gdanski Uniwersytet Medyczny". 1 are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Gdanski Uniwersytet Medyczny, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gdanski Uniwersytet Medyczny, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".